Clinical Trials Browser

Phase 1 × Neoplasms × Histone Deacetylase Inhibitors × Clear all

NCT00697879 2011-11-28

Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours

Phase 1 Completed

Neoplasms